2h
Hosted on MSNOzempic Shows Potential for Alcohol Addiction in TrialWeekly treatment with low doses of the GLP-1 receptor agonist semaglutide (Ozempic) reduced alcohol consumption and craving ...
A new study (the first clinical trial of its kind) has shown that the GLP-1 agonist semaglutide — known by the brand name ...
Results showed that people craved and drank less alcohol when on the drug, according to the findings of a recent study.
A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results